|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 9 of 39 found articles
| Title: |
Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced breast cancer (DAWNA-2): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial |
| Author: |
Zhang, Pin Zhang, Qingyuan Tong, Zhongsheng Sun, Tao Li, Wei Ouyang, Quchang Hu, Xichun Cheng, Ying Yan, Min Pan, Yueyin Teng, Yuee Yan, Xi Wang, Ying Xie, Weimin Zeng, Xiaohua Wang, Xiaojia Hu, Changlu Geng, Cuizhi Zhang, Hongwei Li, Wenxin Wu, Xinhong Zhong, Jincai Xu, Jingwei Shi, Yanxia Wei, Wenhua Bayaxi, Nayima Zhu, Xiaoyu Xu, Binghe |
| Appeared in: |
Lancet oncology |
| Paging: | Volume 24 () nr. 6 pages 646-657 |
| Year: |
2023 |
| Contents: | |
| Publisher: |
Elsevier Ltd |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 9 of 39 found articles
| << previous | next >> |